Literature DB >> 7288486

Cationic Tc-99m complexes as potential myocardial imaging agents.

E Deutsch, K A Glavan, V J Sodd, H Nishiyama, D L Ferguson, S J Lukes.   

Abstract

Nineteen cationic Tc-99m complexes, based upon four different ligand series, have been synthesized under "no carrier added" conditions and qualitatively evaluated as myocardial imaging agents in a dog model. Of these complexes, the four halogen derivatives of the diars series [diars = o-phenylenebis(dimethylarsine)] successfully concentrate in the myocardium. These Tc-99m diars complexes are shown by thin-layer chromatography to be identical to the Tc-99 analogs that have been fully characterized as trans octahedral complexes of Tc(III) by classical chemical techniques. Tissue distribution studies in rats show a definite difference in the biodistributions of [99mTc(diars)2Cl2]+ and [99mTc(diars)2Br2]+, despite the similar size, shape, charge, and lipophilicity of these two complexes. A tissue distribution study in resting beagle dogs shows that [99mTc(diars)2Br2]+ accumulates in the normal myocardium about half as well as TI-201 (0.022 compared with 0.038% dose/g).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7288486

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  23 in total

Review 1.  The development of new radiopharmaceuticals.

Authors:  K E Britton
Journal:  Eur J Nucl Med       Date:  1990

2.  The birth of a new radiopharmaceutical. Industrial perspective: from IND to NDA.

Authors:  L P Giering; J E Smith
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

3.  The utilization of Tc-99m-TBI as a myocardial perfusion agent in exercise studies: comparison with Tl-201 thallous chloride and examination of its biodistribution in humans.

Authors:  S T Sia; B L Holman; K McKusick; P Rigo; F Gillis; V Sporn; N Perez-Balino; A Mitta; H Vosberg; Z Szabo
Journal:  Eur J Nucl Med       Date:  1986

4.  Preliminary evaluation in humans of Tc-99m-Q3, a new tracer for myocardial perfusion imaging.

Authors:  G Bisi; R Sciagrà; L Bacciottini; D Antoniucci; G M Santoro; P Buonamici; C Bonino
Journal:  Int J Card Imaging       Date:  1993-03

5.  99mTc-MIBI (RP-30) to define the extent of myocardial ischemia and evaluate ventricular function.

Authors:  M P Larock; R Cantineau; V Legrand; H Kulbertus; P Rigo
Journal:  Eur J Nucl Med       Date:  1990

6.  Ion-pairing interactions between 99MTc-based myocardial imaging agents and oleic acid.

Authors:  C M Heard; J Hadgraft
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

7.  Myocardial perfusion imaging with 99mTc-methoxy-isobutyl-isonitrile (MIBI): comparison of short and long time intervals between rest and stress injections. Preliminary results.

Authors:  R Taillefer; L Laflamme; G Dupras; M Picard; D C Phaneuf; J Léveillé
Journal:  Eur J Nucl Med       Date:  1988

8.  The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent.

Authors:  S Campbell; B L Holman; J M Kirshenbaum; E M Antman; J Lister-James; A Davison; J Kozlowski; R J English; A G Jones
Journal:  Eur J Nucl Med       Date:  1986

9.  Technetium-99m teboroxime scintigraphy. Clinical experience in patients referred for myocardial perfusion evaluation.

Authors:  L Bontemps; X Geronicola-Trapali; Y Sayegh; O Delmas; R Itti; X André-Fouët
Journal:  Eur J Nucl Med       Date:  1991

10.  Animal and human studies of a new 99mTc labelled phosphine-isocyanide complex with possible applications to radionuclide ventriculography.

Authors:  G D Zanelli; A Lahiri; N Patel; T Smith; F Brady; G Radfar; N D Cook; J C Crawley; D J Silvester
Journal:  Eur J Nucl Med       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.